Webinars & Presentations

Watch how a streamlined, one-step process for the generation of universal CAR T cells can reduce costs and accelerate clinical translation, while maintaining potency and durability in hematological malignancy models.

In this session from the 2025 ISCT annual meeting, MaxCyte moderates a talk with partner Kamau Therapeutics, who shares insights from their journey to clinical trials for nula-cel, a next-generation gene correction therapy for sickle cell disease.

MaxCyte scientist Ashley Strickland-Dietz presents on protocols to improve non-viral engineering of CAR T cells, focusing on primary human T cells.

Watch MaxCyte researcher Isabel Daher present on optimizing VLP manufacturing for high yields in HEK cells using MaxCyte’s Flow Electroporation platform.

MaxCyte researcher Max Van Buskirk discusses how scalable electroporation can enhance transposon delivery in CAR T cell manufacturing workflows.

Watch a presentation about the benefits and challenges of cell-based assays, assay development with MaxCyte electroporation, and transiently transfected assay-ready cells.

Senior Director of Global Business Development Sean Menarguez discusses quality and safety in cell therapy development through the early adoption of GMP-compliant processes. MaxCyte’s regulatory framework and collaboration-minded approach can help reduce downstream risks to bring your therapies to patients sooner and with fewer complications.

MaxCyte Field Application Scientist Dan Miller presents on cell therapy equipment and solutions for the Cell & Gene Tech Expo. Watch how our platform enables streamlined, scalable and high-performance transfection across a wide range of cell types.

MaxCyte scientist Ashley Strickland-Dietz presents on transfecting immune cells using electroporation for the 2025 International Conference on Lymphocyte Engineering. MaxCyte’s electroporation platform ensures efficiency, versatility, scalability and safety for a variety of cell types.

Jim Brady, Senior Vice President of Technical Applications and Customer Support at MaxCyte, presents on how electroporation enables the development and manufacturing of life-changing cellular therapies.